Healthcare · NSE: YATHARTH
Yatharth Hospital & Trauma Care Services
Q2 FY27 earnings and concall highlights
Q2 FY27 earnings call · Guided by management
Call held 4 Nov 2026 · Read the filing on NSEFiling
- M.Cap
- ₹10,301Cr
- P/E
- 54.9×
- 1Y return
- +34.51%
- From 52W high
- −9.7%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 431 | 279 | +54.4% | 393 | +9.9% |
| EBITDA | 102 | 65 | +58.1% | 92 | +11.3% |
| EBITDA margin | 23.6% | 23.1% | +56 bps | 23.4% | +30 bps |
| PBTProfit before tax | 66 | 55 | +19.7% | 61 | +7.2% |
| Net profit | 51 | 41 | +22.7% | 47 | +7.5% |
| EPS (₹) | 5.25 | 4.28 | +22.7% | 4.88 | +7.6% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
EBITDA margin guidance unchanged despite oncology pricing difference
Yatharth Tyagi · Whole · Q&A · p. 14
EBITDA margin guidance unchanged despite oncology pricing difference
“I think the guidance remains the same. In fact, we also have to cover up the difference from the oncology pricing differences. But we remain sure that the guidance we have for the EBITDA margins will continue to be the same.”
Group ARPOB expected to improve in coming years as premium hospitals scale up
Pankaj Prabhakar · Group Chief Financial Officer · p. 5
Group ARPOB expected to improve in coming years as premium hospitals scale up
“As some of our newer and premium hospitals are scaling up and the specialty mix continues to improve, we expect our group ARPOB to improve meaningfully in the coming years.”
Group EBITDA guidance will not change because of the cancer drug pricing policy
Yatharth Tyagi · Whole · Q&A · p. 8
Group EBITDA guidance will not change because of the cancer drug pricing policy
“Our overall group level EBITDA will not change going forward because of this policy.”
More figures from the call
“That is why you would see a slight dip in the OCF conversion rate. But at the end of the year, we should expect upwards of 70% conversion.”
“With Advent as a partner, we now aim to build a larger franchise of 7,000 to 8,000 beds over the next three to five years.”
“The breakup of the expansion is that on our existing organic plan, we had announced going to 5,000 bed capacity, close to three to four years going forward. That remains the same.”
“On top of that, around 2,000 to 3,000 beds we expect to add because of this recent deal, again, in close to four years going forward.”
“So maybe around 40%-50% of those beds can actually go live from the next financial year itself.”
“Next is Gurugram, our upcoming 250-bedded hospital in Sector 40, which is progressing well and is expected to operationalize in the next financial year.”
In short
- 01Advent International to invest INR3,150 crore via preferential issue; first tranche INR1,750 crore after CCI approval.
- 02Company aims for 7,000 to 8,000 beds over the next three to five years.
- 03Organic plan of 5,000 beds kept; Advent money to add about 2,000 beds by acquiring EBITDA-positive hospitals.
- 04EBITDA margin guidance of upwards of 24% kept despite about 0.3% hit from cancer drug margin cap.
- 05Organic revenue growth of 30% a year seen for the next three to four years.
- 06Q2 FY27 revenue INR4,314 million, up 52%; EBITDA INR1,020 million, margin 23.6%.
- 07Model Town Delhi hospital expected to break even in December; Gurugram 250-bed hospital due next financial year.
- 08Management says debt is at its peak level and will go down from here.
Capex
Model Town, Delhi: Radiation oncology at Model Town expected in about eight to nine months
8–9monthsYatharth Tyagi · Whole · Q&A · p. 13
Model Town, Delhi: Radiation oncology at Model Town expected in about eight to nine months
8–9months“As Amit mentioned, we will be adding radiation oncology in that hospital. I think the timeline should be somewhere around close to eight to nine months.”
Gurugram Sector 40: Gurugram building being modified; rest of construction to start after plan approval
Ashutosh Kumar Jha · Group Chief · Q&A · p. 16
Gurugram Sector 40: Gurugram building being modified; rest of construction to start after plan approval
“We have submitted the plans also, and we have started modifying the existing building according to the plan. As soon as we get the plan approval, we will start the construction on the remaining part of it.”
Agra: Agra facility to be renovated and more beds added
Yatharth Tyagi · Whole · Q&A · p. 12
Agra: Agra facility to be renovated and more beds added
“I think going forward, we are not just optimizing payer mix there, but we are planning to renovate the facility as well as add certain more beds, and certain floors are also in a renovation stage there.”
Faridabad Sector-20: Radiation and nuclear oncology at Faridabad Sector-20 to start in next two months
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 13
Faridabad Sector-20: Radiation and nuclear oncology at Faridabad Sector-20 to start in next two months
“The radiation and nuclear, we're going to start in the next two months. So, this is Sector 20.”
Greater Noida: Nuclear and radiation oncology to be added at Greater Noida
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 17
Greater Noida: Nuclear and radiation oncology to be added at Greater Noida
“And we are very confident that in Greater Noida, when we have our entire spectrum, and very soon we are going to add nuclear as well as radiation oncology in Greater Noida facility as well.”
Capacity
Occupancy 72% on currently operational beds
Yatharth Tyagi · Whole · p. 4
Occupancy 72% on currently operational beds
“Our occupancy stood at a healthy 72% on the currently operationalized beds.”
Faridabad, Model Town, Agra: About 350 to 400 beds yet to be opened at Faridabad, Model Town and Agra
Yatharth Tyagi · Whole · p. 4
Faridabad, Model Town, Agra: About 350 to 400 beds yet to be opened at Faridabad, Model Town and Agra
“As we ramp up, about 350 to 400 beds are yet to be operationalized across Faridabad, Model Town, and Agra, presenting meaningful headroom for growth.”
All remaining beds expected to open within two to three quarters
2–3quartersAshutosh Kumar Jha · Group Chief · Q&A · p. 7
All remaining beds expected to open within two to three quarters
2–3quarters“I think within the next couple of quarters, maybe two to three quarters, we should be opening all the beds.”
Model Town, Faridabad, Agra: Occupancy: Model Town 41%, new Faridabad 59%, Agra 58%
Nitin Gupta · President Finance and Group Chief Operating Officer · Q&A · p. 7
Model Town, Faridabad, Agra: Occupancy: Model Town 41%, new Faridabad 59%, Agra 58%
“However, as you asked about Model Town, it has increased to 41% in this quarter. The new hospital at Faridabad has increased to 59%, and Agra has been at 58% as of now.”
Noida, Greater Faridabad, Jhansi: No brownfield expansion plans at Noida, Greater Faridabad and Jhansi
Yatharth Tyagi · Whole · Q&A · p. 14
Noida, Greater Faridabad, Jhansi: No brownfield expansion plans at Noida, Greater Faridabad and Jhansi
“But there are no specific plans for any brownfield capacity expansion in those hospitals.”
Segments
Gurugram: Gurugram hospital expected ARPOB above INR50,000
Yatharth Tyagi · Whole · p. 5
Gurugram: Gurugram hospital expected ARPOB above INR50,000
“The hospital is expected to serve the premium Gurugram market, given its location in a high-potential catchment and its proximity to the Delhi airport, with an anticipated ARPOB of above INR50,000.”
Gurugram: Gurugram hospital targeted to break even in 15 months
Yatharth Tyagi · Whole · Q&A · p. 15
Gurugram: Gurugram hospital targeted to break even in 15 months
“I think Gurugram, we are also targeting to break even in 15 months.”
Model Town, Delhi: December expected to be break-even month for Delhi Model Town hospital
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 13
Model Town, Delhi: December expected to be break-even month for Delhi Model Town hospital
“Next quarter, we are very sure that December will be the break-even month for the Delhi hospital.”
Model Town, Delhi: Model Town losses fell from INR55 million in Q1 to INR38 million in Q2
₹3.8CrAmit Kumar Singh · Group Chief Executive Officer · Q&A · p. 13
Model Town, Delhi: Model Town losses fell from INR55 million in Q1 to INR38 million in Q2
₹3.8Cr“For Q1, losses were INR55 million. This quarter we reported losses of INR38 million.”
Model Town, Delhi: Model Town Q2 revenue about INR26 crores with ARPOB around INR50,000
Yatharth Tyagi · Whole · p. 4
Model Town, Delhi: Model Town Q2 revenue about INR26 crores with ARPOB around INR50,000
“In quarter 2, it reported revenue of approximately INR26 crores and ARPOB of around INR50,000, which places it among the premium hospitals in NCR, alongside Noida Extension, where ARPOB has also crossed INR50,000.”
Demand
international: International business still single digit share; CIS among contributing regions
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 11
international: International business still single digit share; CIS among contributing regions
“However, it is still in single digits as a share of the top line, but we are making a very significant move and various regions like CIS are contributing.”
international: Noida airport opening for international market expected to add to international business
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 11
international: Noida airport opening for international market expected to add to international business
“The next three to four years are going to be fantastic because Noida airport has still not opened for the international market. That is going to be a significant addition for us.”
Greater Noida oncology: No impact on oncology volumes from nearby new cancer centre
Yatharth Tyagi · Whole · Q&A · p. 16
Greater Noida oncology: No impact on oncology volumes from nearby new cancer centre
“So, so far there is no impact in terms of the volume.”
international: International business grew more than 35% in H1 this year vs H2 last year
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 11
international: International business grew more than 35% in H1 this year vs H2 last year
“this year H1, our international business has grown by more than 35%.”
Greater Noida oncology: Oncology volume increased at Greater Noida and Noida Extension; more doctors being added
Yatharth Tyagi · Whole · Q&A · p. 16
Greater Noida oncology: Oncology volume increased at Greater Noida and Noida Extension; more doctors being added
“In fact, if you look at it, our absolute volume of oncology business has increased in both these hospitals. We are adding more doctors also in terms of leading doctors of NCR.”
Margins and costs
Q2 EBITDA INR1,020 million, up 50%; EBITDA margin 23.6%
Pankaj Prabhakar · Group Chief Financial Officer · p. 6
Q2 EBITDA INR1,020 million, up 50%; EBITDA margin 23.6%
“Quarter 2 EBITDA was a record INR1,020 million, increasing 50% year-on-year and 11% quarter-on-quarter. EBITDA margin improved to 23.6% as the newer hospitals are now running profitably.”
Adjusted EBITDA margin 28% excluding New Delhi and Faridabad Sector-20 ramp-up losses
Pankaj Prabhakar · Group Chief Financial Officer · p. 6
Adjusted EBITDA margin 28% excluding New Delhi and Faridabad Sector-20 ramp-up losses
“Excluding the ramp-up losses at New Delhi and Faridabad Sector-20, our adjusted EBITDA margin was healthy at 28%.”
Noida, Greater Noida, Noida Extension, Jhansi-Orchha: Existing hospitals' EBITDA margin upwards of 28%
Yatharth Tyagi · Whole · p. 3
Noida, Greater Noida, Noida Extension, Jhansi-Orchha: Existing hospitals' EBITDA margin upwards of 28%
“These have been true contributors to our profitability, with an EBITDA margin upwards of 28% for these specific hospitals.”
oncology: Plans to offset 0.3% cancer drug impact through other operating efficiencies
Yatharth Tyagi · Whole · Q&A · p. 8
oncology: Plans to offset 0.3% cancer drug impact through other operating efficiencies
“For this 0.3% reduction in cancer drugs, we are already figuring out and coming up with strategies to compensate this into other operational efficiencies and line items and other ways of compensating for this.”
Faridabad, Delhi: Faridabad and Delhi hospitals to start offsetting any margin drag
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 14
Faridabad, Delhi: Faridabad and Delhi hospitals to start offsetting any margin drag
“Just remember that our existing hospitals, particularly Faridabad and Delhi, will start contributing to offset whatever the drag would be.”
Debt and working capital
H1 operating cash flow INR1,113 million, up 49% year-on-year
Pankaj Prabhakar · Group Chief Financial Officer · p. 6
H1 operating cash flow INR1,113 million, up 49% year-on-year
“Our operating cash flow during H1 was INR1,113 million, an increase of 49% year-on-year.”
Cash and bank INR4,289 million; net debt INR392 million at September 30, 2026
₹39.2CrPankaj Prabhakar · Group Chief Financial Officer · p. 6
Cash and bank INR4,289 million; net debt INR392 million at September 30, 2026
₹39.2Cr“As of September 30, 2026, the cash and bank balances stood at INR4,289 million, and net debt stood at INR392 million.”
Debt at peak level for the next few quarters; expected to go down from here
Yatharth Tyagi · Whole · Q&A · p. 12
Debt at peak level for the next few quarters; expected to go down from here
“But we feel that this is the peak level of debt for us, at least for the next few quarters to come. Debt will eventually go down from here.”
If acquisitions take time, Advent money may be used to reduce debt marginally
Yatharth Tyagi · Whole · Q&A · p. 12
If acquisitions take time, Advent money may be used to reduce debt marginally
“if the acquisitions take time as far as certain assets are concerned, we can also look to reduce debt marginally from that amount.”
Model Town, Faridabad Sector-20, Gurugram: Around INR100 crores or more of debt taken for medical equipment and Gurugram construction
Yatharth Tyagi · Whole · Q&A · p. 12
Model Town, Faridabad Sector-20, Gurugram: Around INR100 crores or more of debt taken for medical equipment and Gurugram construction
“around INR100 crores or more has been taken for certain medical equipment that will be -- and that has been added to both the Model Town Hospital, the Sector 20 Faridabad Hospital, as well as certain construction that is already happening in full swing in the Gurugram Hospital.”
Fund raising
Advent International to invest INR3,150 crores through preferential issue of shares and warrants
Yatharth Tyagi · Whole · p. 3
Advent International to invest INR3,150 crores through preferential issue of shares and warrants
“we have entered into a strategic partnership with Advent International for a primary capital investment of INR3,150 crores through a preferential issue of equity shares and warrants.”
Advent money in two tranches; first tranche INR1,750 crores after CCI approval this month
Ashutosh Kumar Jha · Group Chief · Q&A · p. 8
Advent money in two tranches; first tranche INR1,750 crores after CCI approval this month
“So the Advent money of INR3,150 crores will come in two tranches. The first tranche will be INR1,750 crores, which will be received after the CCI approval this month.”
Second Advent tranche expected after 15 to 18 months, based on conditions
Ashutosh Kumar Jha · Group Chief · Q&A · p. 8
Second Advent tranche expected after 15 to 18 months, based on conditions
“And the next tranche will be received after 15 to 18 months based on certain conditions.”
Advent deal at final stage of CCI approval; approval expected this month
Yatharth Tyagi · Whole · Q&A · p. 8
Advent deal at final stage of CCI approval; approval expected this month
“Yes, I think the Advent deal is at the CCI approvals final stages. I think post Diwali, we can expect it to get the approval this month itself.”
Acquisitions and new business
Advent money to buy running, EBITDA-positive assets totalling close to 2,000 beds
Yatharth Tyagi · Whole · Q&A · p. 11
Advent money to buy running, EBITDA-positive assets totalling close to 2,000 beds
“As we said that we will be acquiring running assets, we will be acquiring EBITDA positive assets, and the total bed capacity that we can look to add from that amount should be close to 2,000 beds in total.”
Acquisition focus on multi-specialty hospitals, larger deals and hospital chains
Ashutosh Kumar Jha · Group Chief · Q&A · p. 8
Acquisition focus on multi-specialty hospitals, larger deals and hospital chains
“Our focus remains on multi-specialty hospitals. Now we are, of course, looking at much larger deals, and we are looking for a chain of hospitals also.”
Hospitals acquired with Advent funds will always be EBITDA positive
Yatharth Tyagi · Whole · Q&A · p. 8
Hospitals acquired with Advent funds will always be EBITDA positive
“Also, the assets that we will continue to acquire from this fund will always be EBITDA positive hospitals. There will be no absolute drag on the absolute EBITDA because of these acquisitions going forward.”
No greenfield assets from Advent money; not targeting fully stressed assets
Yatharth Tyagi · Whole · Q&A · p. 17
No greenfield assets from Advent money; not targeting fully stressed assets
“I think specifically from the Advent money, we are not creating any greenfield assets, and we might not be going for absolutely stressed assets.”
Advent capital to go mostly into fully owned assets
Yatharth Tyagi · Whole · Q&A · p. 15
Advent capital to go mostly into fully owned assets
“But from the new Advent capital, it would mostly be fully owned assets.”
Risks
oncology: Cancer drug margin cap of 30% reduces EBITDA by around 0.3%
Yatharth Tyagi · Whole · Q&A · p. 7
oncology: Cancer drug margin cap of 30% reduces EBITDA by around 0.3%
“We have calculated that, for the existing list of cancer drugs where margins are capped at 30%, the overall impact on our EBITDA numbers is a reduction of around 0.3% because of that specific pricing on oncology drugs.”
international: International business affected in recent months by war and Gulf situation
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 11
international: International business affected in recent months by war and Gulf situation
“However, it has been affected in the last couple of months because of the war , gulf situation and other things.”
Model Town, Delhi: Delhi construction on hold under GRAP 2
Amit Kumar Singh · Group Chief Executive Officer · Q&A · p. 13
Model Town, Delhi: Delhi construction on hold under GRAP 2
“As you know, Delhi is under GRAP 2 now, so construction is on hold.”
Income tax matter resolved with final demand
Yatharth Tyagi · Whole · Q&A · p. 12
Income tax matter resolved with final demand
“As we were saying, the final demand has come and the matter is resolved now.”
Company advised to appeal against income tax demand
Yatharth Tyagi · Whole · Q&A · p. 13
Company advised to appeal against income tax demand
“Based on legal opinions and even talks with the department itself, we have been advised to appeal against that.”
Other
Q2 FY27 revenue INR4,314 million, up 52% year-on-year and 10% sequentially
Pankaj Prabhakar · Group Chief Financial Officer · p. 5
Q2 FY27 revenue INR4,314 million, up 52% year-on-year and 10% sequentially
“The group delivered its highest-ever quarterly revenue of INR4,314 million in quarter 2 FY27, representing growth of 52% year-on-year and 10% sequentially.”
Q2 profit after tax INR485 million, up 17%; H1 PAT INR939 million
Pankaj Prabhakar · Group Chief Financial Officer · p. 6
Q2 profit after tax INR485 million, up 17%; H1 PAT INR939 million
“Profit after tax stood at INR485 million for quarter 2, up 17% year-on-year, and INR939 million for H1.”
Group ARPOB INR36,000, up 11% year-on-year
Pankaj Prabhakar · Group Chief Financial Officer · p. 5
Group ARPOB INR36,000, up 11% year-on-year
“Group ARPOB reached an all-time high of INR36,000, up 11% year-on-year.”
Government payer mix 34% this quarter vs 37% last quarter
Yatharth Tyagi · Whole · Q&A · p. 6
Government payer mix 34% this quarter vs 37% last quarter
“34% is this quarter's government mix, and last quarter it was 37%.”
international: International business around 4%-5%
Yatharth Tyagi · Whole · Q&A · p. 6
international: International business around 4%-5%
“The international business remains close to around 4%-5% at the current payment level.”
Sources
- Earnings call transcript, Q2 FY27 Filed 12 Nov 2026 · 19 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

